[Federal Register: November 9, 1998 (Volume 63, Number 216)]
[Notices]               
[Page 60362-60363]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09no98-104]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
Meeting of the Cancer Advisory Panel for Complementary and 
Alternative Medicine

    Notice is hereby given of the first meeting of the Cancer Advisory 
Panel for Complementary and Alternative Medicine (CAP), November 16, 
1998, at the DoubleTree Hotel, 1750 Rockville Pike, Rockville, Maryland 
20852. The meeting is scheduled from 8:30 am to 5 pm and is open to the 
public. Attendance by the public will be limited to space available.
    The Panel's primary responsibility is to provide expert review and 
evaluation of summaries of evidence for complementary and alternative 
medicine cancer claims by practitioners. The information compiled and 
evaluated by each member of the Panel will be provided to the Office of 
Alternative Medicine's chartered Alternative Medicine Program Advisory

[[Page 60363]]

Council (AMPAC) to be used during its deliberations.
    The agenda includes: (1) An overview of the structure and role of 
the CAP; (2) a presentation on the National Cancer Institute-funded 
research mechanism; (3) an overview of current Office of Alternative 
Medicine (OAM) projects; (4) a discussion of potential future cancer 
clinical trials initiatives related to complementary and alternative 
medicine; and (5) a public comment session.
    The public comment session is scheduled from 3 p.m. to 5 p.m. Each 
speaker will be permitted 5 minutes for their presentation. Interested 
individuals and representatives of organizations are requested to 
notify D. Geoffrey Cheung, Office of Alternative Medicine, NIH, 31 
Center Drive, (MSC 2182), Building 31, Room 5B37, Bethesda, MD 20892, 
(301) 594-2013, FAX: (301) 594-6757. Letters of intent to present 
comments, along with a brief description of the organization 
represented, should be received no later than 5:00 p.m. on Thursday, 
November 12. Only one representative of an organization may present 
oral comments. Any person attending the meeting who does not request an 
opportunity to speak in advance of the meeting may be considered for 
oral presentation, if time permits, and at the discretion of the 
Chairperson. In addition, written comments may be submitted to Dr. 
Geoffry Cheung at the address listed above up to ten days following the 
meeting.
    For additional information please contact Ms. Odessa Colvin, 
Program Assistant, OAM, 31 Center Drive, MSC 2182, Building 31, Room 
5B37, Bethesda, Maryland, 20892, (301-435-5175). Individuals who plan 
to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should contact Ms. 
Colvin in advance of the meeting.

    Dated: November 2, 1998.
Ruth L. Kirschstein,
Deputy Director, National Institute of Health.
[FR Doc. 98-29984 Filed 11-6-98; 8:45 am]
BILLING CODE 4140-01-M